Published study further demonstrates in vitro activity of SCY-078 against Aspergillus strains when used alone or in combination
Clinical efficacy against Aspergillus strains to be tested in Phase 2 trial to begin in third quarter of 2018
Antifungal activity against Pneumocystis supports potential use for prophylaxis indications
PR Newswire
JERSEY CITY, N.J., April 23, 2018